JP2004525183A5 - - Google Patents

Download PDF

Info

Publication number
JP2004525183A5
JP2004525183A5 JP2002581418A JP2002581418A JP2004525183A5 JP 2004525183 A5 JP2004525183 A5 JP 2004525183A5 JP 2002581418 A JP2002581418 A JP 2002581418A JP 2002581418 A JP2002581418 A JP 2002581418A JP 2004525183 A5 JP2004525183 A5 JP 2004525183A5
Authority
JP
Japan
Prior art keywords
formula
alkyl
aryl
compound
compound represented
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002581418A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004525183A (ja
Filing date
Publication date
Priority claimed from GBGB0109123.0A external-priority patent/GB0109123D0/en
Priority claimed from GB0205649A external-priority patent/GB0205649D0/en
Application filed filed Critical
Priority claimed from PCT/EP2002/004066 external-priority patent/WO2002083663A1/en
Publication of JP2004525183A publication Critical patent/JP2004525183A/ja
Publication of JP2004525183A5 publication Critical patent/JP2004525183A5/ja
Pending legal-status Critical Current

Links

JP2002581418A 2001-04-11 2002-04-11 Nk−3およびnk−2受容体アンタゴニストとしてのキノリン−4−カルボキサミド誘導体 Pending JP2004525183A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0109123.0A GB0109123D0 (en) 2001-04-11 2001-04-11 Novel compounds
GB0205649A GB0205649D0 (en) 2002-03-11 2002-03-11 Novel compounds
PCT/EP2002/004066 WO2002083663A1 (en) 2001-04-11 2002-04-11 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists

Publications (2)

Publication Number Publication Date
JP2004525183A JP2004525183A (ja) 2004-08-19
JP2004525183A5 true JP2004525183A5 (US07981874-20110719-C00313.png) 2005-12-22

Family

ID=26245967

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2002581418A Pending JP2004525183A (ja) 2001-04-11 2002-04-11 Nk−3およびnk−2受容体アンタゴニストとしてのキノリン−4−カルボキサミド誘導体
JP2002581419A Pending JP2004525184A (ja) 2001-04-11 2002-04-11 Nk−3およびnk−2受容体アンタゴニストとしての3−置換キノリン−4−カルボキサミド誘導体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2002581419A Pending JP2004525184A (ja) 2001-04-11 2002-04-11 Nk−3およびnk−2受容体アンタゴニストとしての3−置換キノリン−4−カルボキサミド誘導体

Country Status (7)

Country Link
US (5) US20040152726A1 (US07981874-20110719-C00313.png)
EP (3) EP1385839B1 (US07981874-20110719-C00313.png)
JP (2) JP2004525183A (US07981874-20110719-C00313.png)
AT (2) ATE313539T1 (US07981874-20110719-C00313.png)
DE (2) DE60209362T2 (US07981874-20110719-C00313.png)
ES (2) ES2259096T3 (US07981874-20110719-C00313.png)
WO (2) WO2002083663A1 (US07981874-20110719-C00313.png)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070060593A1 (en) * 2003-06-25 2007-03-15 Kerns Jeffrey K 4-Carboxamido quinoline derivatives for use as nk-2 and nk-3
ITMI20031292A1 (it) * 2003-06-25 2004-12-26 Nikem Research Srl Derivati biciclici nk-2 antagonisti selettivi.
ATE416176T1 (de) 2004-04-28 2008-12-15 Takeda Pharmaceutical Kondensierte chinolinderivate und deren anwendung
GB0417702D0 (en) * 2004-08-09 2004-09-08 Merck Sharp & Dohme New uses
GB0425076D0 (en) * 2004-11-12 2004-12-15 Smithkline Beecham Corp Novel compounds
EP1891012A2 (en) * 2005-06-03 2008-02-27 AstraZeneca AB Quinoline derivatives as nk3 anatgonists
WO2006137789A1 (en) * 2005-06-23 2006-12-28 Astrazeneca Ab Quinoline 3 -sulfonate esters as NK3 receptor modulators
GB0515580D0 (en) 2005-07-29 2005-09-07 Merck Sharp & Dohme Therapeutic compounds
AR057130A1 (es) 2005-09-21 2007-11-14 Astrazeneca Ab Quinolinas de alquilsulfoxido y una composicion farmaceutica
WO2007035156A1 (en) * 2005-09-21 2007-03-29 Astrazeneca Ab N-oxo-heterocycle and n-oxo-alkyl quinoline-4-carboxamides as nk-3 receptor ligands
JP2010522177A (ja) * 2007-03-23 2010-07-01 アムジエン・インコーポレーテツド 複素環化合物およびその使用
WO2008153027A1 (ja) * 2007-06-11 2008-12-18 Takeda Pharmaceutical Company Limited ピロロキノリン誘導体およびその用途
WO2009072643A1 (en) 2007-12-03 2009-06-11 Takeda Pharmaceutical Company Limited Nitrogen-containing heterocyclic compound and use thereof
WO2009128262A1 (ja) * 2008-04-15 2009-10-22 武田薬品工業株式会社 キノロン誘導体およびその用途
NZ591265A (en) * 2008-09-15 2013-02-22 Lundbeck & Co As H Isoquinolinone derivatives as nk3 antagonists
US8242134B2 (en) 2008-09-15 2012-08-14 H. Lundbeck A/S Isoquinolinone derivatives as NK3 antagonists
USRE48334E1 (en) 2008-09-19 2020-12-01 Takeda Pharmaceutical Company Limited Nitrogen-containing heterocyclic compound and use of same
CN102584852B (zh) * 2011-12-30 2014-08-13 厦门大学 真菌代谢产物桥南霉素及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2191352C (en) * 1994-05-27 2001-01-30 Carlo Farina Quinoline derivatives as tachykinin nk3 receptor antagonists
AR004735A1 (es) * 1995-11-24 1999-03-10 Smithkline Beecham Spa Quinoleina 4-amido sustituida, un procedimiento para su preparacion, una composicion farmaceutica que los contiene y el uso de los mismos para lapreparacion de un medicamento.
WO1997021680A1 (en) * 1995-11-24 1997-06-19 Smithkline Beecham S.P.A. Quinoline derivatives
WO1998052942A1 (en) * 1997-05-23 1998-11-26 Smithkline Beecham S.P.A. Quinoline-4-carboxamide derivatives as nk-2 and nk-3 receptor antagonists
KR20010075726A (ko) * 1998-11-20 2001-08-09 파올로 비지, 엔리꼬 카쭐라니 Nk-3 및 nk-2 수용체 길항제로서의퀴놀린-4-카르복스아미드 유도체
GB9825554D0 (en) * 1998-11-20 1999-01-13 Smithkline Beecham Spa Novel Compounds

Similar Documents

Publication Publication Date Title
JP2004525183A5 (US07981874-20110719-C00313.png)
RU2361860C2 (ru) Новые замещенные 3-сера-индолы
RU2394028C2 (ru) Производные бензилтриазолона в качестве ненуклеозидных ингибиторов обратной транскриптазы
RU2342383C2 (ru) ПРОИЗВОДНЫЕ ИМИДАЗОЛ-4-ИЛЭТИНИЛПИРИДИНА, СПОСОБ ИХ ПОЛУЧЕНИЯ (ВАРИАНТЫ) И ПРИМЕНЕНИЕ В КАЧЕСТВЕ АНКСИОЛИТИКА, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ И СПОСОБ ЛЕЧЕНИЯ НАРУШЕНИЙ, ОПОСРЕДУЕМЫХ РЕЦЕПТОРОМ mGLuR5
JP2017533968A5 (US07981874-20110719-C00313.png)
JP2008513516A5 (US07981874-20110719-C00313.png)
JP2005536475A5 (US07981874-20110719-C00313.png)
RU2012125372A (ru) Производные пиразола в качестве ингибиторов 11-бета-hsd1
RU2004104625A (ru) Аналоги простагландинов в качестве агонистов рецептора ep4
JP2018519323A5 (US07981874-20110719-C00313.png)
JP2017537949A5 (US07981874-20110719-C00313.png)
RU2009133794A (ru) Гербициды на основе замещенного n-оксида пиридина
JP2012525431A5 (US07981874-20110719-C00313.png)
JP2002529532A5 (US07981874-20110719-C00313.png)
JP2008508214A (ja) 女性の性障害の治療用ピペラジン誘導体
JP2008513498A5 (US07981874-20110719-C00313.png)
JP2010536767A5 (US07981874-20110719-C00313.png)
JP2005522458A5 (US07981874-20110719-C00313.png)
RU2007101236A (ru) Новые гидантоиновые производные для лечения обструктивных заболеваний дыхательных путей
RU2007130144A (ru) Гетероциклические соединения в качестве антагонистов cccr2b
JP2018502148A5 (US07981874-20110719-C00313.png)
JP2020521767A5 (US07981874-20110719-C00313.png)
JP2009501745A5 (US07981874-20110719-C00313.png)
JP2018513190A5 (US07981874-20110719-C00313.png)
JP2004529145A5 (US07981874-20110719-C00313.png)